**Core Concept**
Niacin, also known as nicotinic acid, is a medication used to lower cholesterol levels and reduce the risk of cardiovascular disease. However, its use in diabetic patients requires caution due to its potential to worsen glycemic control.

**Why the Correct Answer is Right**
Niacin can stimulate the release of insulin from the pancreas, but it can also increase glucose production in the liver, leading to hyperglycemia (high blood sugar). This is particularly concerning in diabetic patients, as it may require adjustments to their insulin regimen or other medications to maintain adequate blood sugar control. Additionally, niacin can cause a condition called niacin-induced insulin resistance, where the body becomes less responsive to insulin, further complicating glycemic management.

**Why Each Wrong Option is Incorrect**
**Option A:** Niacin is not typically associated with causing hypoglycemia (low blood sugar) as a primary concern in diabetic patients.
**Option B:** While niacin can have various side effects, its use in diabetic patients is not primarily due to concerns about liver function or toxicity.
**Option C:** Niacin is not typically used to treat diabetes mellitus; instead, it's used to manage dyslipidemia (abnormal levels of lipids in the blood).

**Clinical Pearl / High-Yield Fact**
When using niacin in diabetic patients, it's essential to closely monitor blood glucose levels and adjust insulin regimens as needed to avoid hyperglycemia.

**Correct Answer:** B.